Therapeutic efficacy of lentiviral vector mediated BDNF gene-modified MSCs in cerebral infarction

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 7, 2008, Pages 1174-1179

  Huang, Dongyu ^a,b   Zhang, Zhijian ^a,b   Chen, Bailing ^a,b   Wu, Xiuli ^b   Wang, Ning ^a,b   Zhang, Yanding ^c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN PROVINCIAL HOSPITAL   (China)

^c FUJIAN NORMAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor (BDNF); Cerebral infarction; Intravenous transplantation; Mesenchymal stem cells; Rat

Indexed keywords

LENTIVIRUS; RATTUS;

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CEREBRAL ARTERY DISEASE; CONVALESCENCE; CYTOLOGY; FISCHER 344 RAT; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; LENTIVIRINAE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENETIC VECTORS; INFARCTION, MIDDLE CEREBRAL ARTERY; LENTIVIRUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED F344; RECOVERY OF FUNCTION; TRANSFECTION;

EID: 69749114546     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zhang Y, Pardridge WM. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Research, 2006, 1111(1): 227-229.
2. Sommer C, Kollmar R, Schwab S, et al. Exogenous brain-derived neurotrophic factor prevents postischemic downregulation of [3H]muscimol binding to GABA(A) receptors in the cortical penumbra. Molecular Brain Research, 2003, 111(1-2): 24-30.
3. Hirouchi M, Ukai Y. Current state on development of neuroprotective agents for cerebral ischemia. Nippon Yakurigaku Zasshi, 2002, 120(2): 107-113.
4. Tao H, Rao R, Ma DD, et al. Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition. Development, Growth & Differentiation, 2005, 47(6): 423-433.
5. Feng YD, Zhang SM, Xu YM, et al. The experimental study on rat mesenchymal stem cells induced to differentiate into nerve-like cells in vitro. Chinese Journal of Neuroimmunology and Neurology, 2003, 10(4): 262-267.
6. Huang DY, Zhang ZJ, Chen BL, et al. Construction of rat Bdnf gene lentiviral vector and its expression in mesenchymal stem cells. Chinese Journal of Biotechnology, 2007, 23(2): 235-240.
7. Zea Longa E, Weistein PR, Calson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20(1): 84-91.
8. Ahmad I, Tang L. Identification of neural progenitors in the adult mammalian eye. Biochemical and Biophysical Research Communications, 2000, 270: 5172-5211.
9. Larsson E, Nanobashvili A, Kokaia Z, et al. Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats. Journal of Cerebral Blood Flow and Metabolism, 1999, 19: 1220-1228.
10. Kiprianova I, Freiman TM, Desiderato S, et al. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat. Journal of Neuroscience Research, 1999, 56(1): 21-27.
11. Tao H, Rao R, Ma DD, et al. Cytokine induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell free condition. Development, Growth and Differentiation, 2005, 47(6): 423-433.
12. Long X, Olszewski M, Huang W, et al. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells and Development, 2005, 14(1): 65-69.
13. Ying QL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature, 2002, 416: 545-548.
14. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone marrow derived hepatocytes. Nature, 2003, 422: 897-901.
15. Li Y, Chen J, Zhang CL, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia, 2005, 49(3): 407-417.
16. Crigler L, Robey RC, Asawachaicharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuroregulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology, 2006, 198(1): 54-64.
17. Zhang ZJ, Wang W, Chen SY, et al. Effect of intravenous administration of rat mesenchymal stem cells after cerebral ischemia in rats. Journal of Fujian Medical University, 2007, 41(2): 114-117.
18. Chen DP, Zhang ZJ, Wu XL, et al. Distribution of intravenously grafted bone marrow mesenchymal stem cells in the viscera tissues of rats before and after cerebral ischemia. Jouranl of Clinical Rehabilitative Tissue Engineering Research, 2007, 11(50): 10160-10164.
19. Zhang ZJ, Zhang JL, Chen DP, et al. Effect of Stromal Cell-derived Factor-1 on the Migration of Mesenchymal Stem Cells. Chinese Journal of Clinical Neurosciences, 2006, 14(6), 571-576.
20. Zhao LX, Zhang J, Cao F, et al. Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and neuroprotection. Experimental Neurology, 2004, 190(2): 396-406.
21. Kurozumi K, Nakamura K, Tamiya T, et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Molecular Therapy, 2004, 2(9): 189-197.
22. Nomura T, Honmou O, Harada K, et al. I. v. infusion of brain-derived neurotrophic factor gene modified-human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience, 2005, 136(1): 161-169.
23. Wang W, Zhang ZJ, Wu XL, et al. Comparison of Intravenous Administrating of rMSO and fBMC after Cerebral Ischemia in Adult Rats. Journal of Fujian Medical University, 2008, 42(1): 1-5.